RNAZ · Forms 3, 4, 5
Insider trades at Transcode Therapeutics, Inc.
No open-market insider buys or sells at Transcode Therapeutics, Inc. in the last 90 days; 4 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Transcode Therapeutics, Inc. (RNAZ) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| John A Tattory | Interim CFO | Became an insider (Form 3) | Form 3 | ||||
| Thomas A Fitzgerald | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| DEFJ, LLC | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| DEFJ, LLC | 10% owner | Conversion | 11,813,859 | Form 4 | |||
| DEFJ, LLC | 10% owner | Conversion | 2,020,582 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.